Dr. Anna Wilkinson, a family physician at the Ottawa Hospital with a special interest in oncology, has received a $10,000 clinical grant from Prostate Cancer Foundation Canada to research how changes in PSA screening recommendations have impacted prostate cancer outcomes in Canada.
To attend in person
- Please register early by e-mail at: .(JavaScript must be enabled to view this email address), and please ensure that you include the number of attendees in your party.
- By email, we’ll either confirm your reservation, or advise you that we’ve reached the Centre’s capacity of 24 persons
Note: Masks are not mandatory but are recommended in the Maplesoft-Jones Centre
To attend virtually by Zoom
- To register, please click on this link. After registering, you’ll receive an email with instructions for joining the meeting.
Our Guest Speaker Dr. Anna Wilkinson – PSA Screening Effects
Prostate cancer is the most frequently diagnosed cancer among Canadian men, excluding non-melanoma skin cancers, and remains a significant cause of cancer-related deaths. Early stage prostate cancer has excellent survival, but advanced stages see a marked decrease in survival.
Prostate-specific antigen (PSA) can be used to screen for prostate cancer, finding cases before they present with symptoms at a later stage. PSA screening is controversial due to concerns about over-diagnosis and unnecessary treatment. Over the years screening recommendations have evolved, influencing screening practices. It is important to monitor prostate cancer outcomes relative to screening recommendations to assess the impact of any recommendations.
This study aims to analyze Canadian Cancer Registry data to explore how changing recommendations for or against PSA screening have influenced prostate cancer outcomes. By examining trends in prostate cancer incidence, mortality, and stage distribution across age groups relative to screening guideline changes, the study will provide insights into whether the recommendation against prostate cancer screening has led to worse prostate cancer outcomes.
The findings will contribute to a better understanding of how prostate cancer screening guidelines impact prostate cancer detection and outcomes. Ultimately, this research aims to inform future guidelines to improve prostate cancer screening practices in Canada.
Monthly Social Drop-Ins
Please come on out and join us in person for relaxed social drop-ins at the Maplesoft-Jones Centre. All are welcome – members, newcomers, and partners/caregivers.
These new monthly PCSO meetings will start at 6:00 pm in the Great Room of the Maplesoft-Jones Centre, 1500 Alta Vista Drive [MAP], every first Thursday of the month except July and August. These are in-person only events, with coffee and light refreshments available. Check our Meetings page for details.
We hope to see you there!
Regular PCS Ottawa Meetings
Unless otherwise noted, we hold Prostate Cancer Support Ottawa’s regular monthly meetings at the Maplesoft-Jones Cancer Survivorship Centre [Map] on the third Thursday of each month. We don’t hold meetings in the months of July and August, except for our ever-popular annual BBQ on the third Thursday of August.
We offer most of our meetings in hybrid format, allowing you to attend either in person or virtually. Watch our Meetings and Events website page or your e-mail inbox for meeting locations and specific registration instructions.
We normally start our meetings with a social gathering at 5:30 pm, followed at 6:00 pm with brief business announcements, followed by either a guest speaker or a sharing session.
We thank you for your continued support!
Not sure where to start?
We are only a phone call or email away. Contact PCSO anytime at 613-828-0762 or .(JavaScript must be enabled to view this email address).